Liraglutide

Product NDC
70748-346
11-digit product format
707480346
Labeler code
70748
Product ID
70748-346_e829ecbe-8005-412e-a0a1-65b44265050f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Liraglutide
Dosage form
INJECTION
Route
SUBCUTANEOUS
Labeler
Lupin Pharmaceuticals, Inc.
Application
ANDA215421
Marketing category
ANDA
Marketing start
2025-10-02
Substance
LIRAGLUTIDE
Active strength
6 mg/mL
Pharmacologic classes
GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A215421-001LIRAGLUTIDELIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP12025-07-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A215421-001AP1

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A215421-001LIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP12025-07-22caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A215421-001LIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP12025-07-22011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215421-001LIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP12025-07-2231067a03dcf5…
2025-08-23 18:47 UTC2025-08A215421-001LIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP2025-07-226a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215421-001LIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP12025-07-22a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A215421-001AP11caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A215421-001AP11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215421-001AP1131067a03dcf5…
2025-08-23 18:47 UTC2025-08A215421-001AP16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215421-001AP11a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Liraglutide
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LIRAGLUTIDE6 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
839I73S42AInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
897122Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0450d8a2-a88e-4849-9788-ed4f5246f223Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d8dac6c8-0045-42cf-b357-c3350b4ada5cProduct name220251021
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727
0dd952e2-ff48-4739-9b8d-72ae0b326834Product name220200323
ce962b7e-f9f8-43e6-8d30-41514e79f3e4Product name120190201
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
2f360a13-6ea8-4c2b-b2ef-10133c2836d9Product name120150316

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70748-346-02Liraglutide3 mL in 1 SYRINGE, PLASTICINJECTION310
70748-346-02Liraglutide2 in 1 CARTONINJECTION210
70748-346-03Liraglutide3 mL in 1 SYRINGE, PLASTICINJECTION310
70748-346-03Liraglutide3 in 1 CARTONINJECTION310

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70748-346-02ML - Milliliter70748-34639b8bc3c-5b76-440d-86c4-8e69f540b41012025-10-14
70748-346-03ML - Milliliter70748-346d2a4c0bf-f5ab-4b3e-9ec3-623ec3a7718a12025-10-14

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LiraglutideLIRAGLUTIDELupin Pharmaceuticals, Inc.0450d8a2-a88e-4849-9788-ed4f5246f2232025-11-13Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215421
application number: ANDA215421
ndc (product): 70748-346

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
897122liraglutide 6 MG/ML in 3 ML Pen InjectorPSN0450d8a2-a88e-4849-9788-ed4f5246f22310
8971223 ML liraglutide 6 MG/ML Pen InjectorSCD0450d8a2-a88e-4849-9788-ed4f5246f22310
897122liraglutide 18 MG per 3 ML Pen InjectorSY0450d8a2-a88e-4849-9788-ed4f5246f22310

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70748-346-02707480346022 SYRINGE, PLASTIC in 1 CARTON (70748-346-02) / 3 mL in 1 SYRINGE, PLASTIC2025-10-02NoNoCurrent
70748-346-03707480346033 SYRINGE, PLASTIC in 1 CARTON (70748-346-03) / 3 mL in 1 SYRINGE, PLASTIC2025-10-02NoNoCurrent